March 7th, 2018 at 5:35 am UTC · 2 mins read
Patientory Stiftung is a Swiss non-profit organization responsible for the blockchain technology that provides the infrastructure for Patientory, Inc. The red logo is a thing of the past after months of legal battles with the Red Cross and Blue Cross Blue Shield. As a result, The Patientory Stiftung and Patientory Inc. brand colors have shifted from red to green.
Mohsen Shafaei, former CEO/President of Hitachi Europe and Vice President of Siemens Healthcare, will lead the Patientory Stiftung as Executive Director. Both the Patientory Inc. and Patientory Stiftung team will host their first live AMA March 22, 2018. The teams will answer questions related to blockchain technology, the new interface, pilot programs, potential clients, the Inaugural Patientory Stiftung Summit scheduled May 31, 2018, in Atlanta, GA and more.
The Patientory Stiftung Switzerland is a non-profit membership organization founded to promote and develop new technologies and applications in the healthcare industry, especially in the fields of open source distributed ledger technologies (DLT) and decentralized software architectures.
Patientory Stiftung focuses on securely storing and managing health information in real time. The storage and management will be facilitated by a blockchain based token (called “PTOY”). The Patientory Stiftung promotes the PTOY platform in commerce as a whole by helping develop standards that are essential to the implementation and adoption of the PTOY blockchain platform and token in securely protecting and managing healthcare information.
Patientory, Inc. is empowering people to take charge of their health. Patientory connects doctors, care providers, and consumers all within a single, secure platform – creating a care team that works together to provide the best care. We’re revolutionizing the way doctors, and patients interact and gain access to information, cutting out all layers and processes that currently are stumbling blocks in care coordination.
Disclaimer: This publication is sponsored. Coinspeaker does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or other materials on this web page. Readers are advised to conduct their own research before engaging with any company mentioned. Please note that the featured information is not intended as, and shall not be understood or construed as legal, tax, investment, financial, or other advice. Nothing contained on this web page constitutes a solicitation, recommendation, endorsement, or offer by Coinspeaker or any third party service provider to buy or sell any cryptoassets or other financial instruments. Crypto assets are a high-risk investment. You should consider whether you understand the possibility of losing money due to leverage. None of the material should be considered as investment advice. Coinspeaker shall not be held liable, directly or indirectly, for any damages or losses arising from the use or reliance on any content, goods, or services featured on this web page.